Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ceplene histamine: Phase II

MAXM completed enrollment of 302 patients in an international 72-week, Phase II

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE